Clinical Trials
2 trialsNCT00768144 2018-08-24
Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00388037 2015-01-27
Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed